Notably, cancer cells were more susceptible to HDAC8 inhibition, as both HDAC8 inhibitors induced greater checkpoint activation in MDA-MB-231 cells compared with normal M10 cells (Figure 5B). This evidence concerns the gene HDAC8 and cancer.